127P Phase I Study of Fianlimab: A Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination with Cemiplimab in Advanced NSCLC
JOURNAL OF THORACIC ONCOLOGY(2024)
Key words
PD-1 and PD-L1
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined